Social Media Ideas for Biotech

Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence

The deal would add Bio-Techne’s multiomics offerings, analytical technologies, and integrated workflow solutions to German Merck’s platforms and services in research, bioprocessing...

Fueled by M&A and partnerships, biotech is poised for continued growth: EY

Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum into 2026, as the volume and value of licensing and M&A deals continues to increase. N...

India's biotech push reaches an inflection point, but funding remains the missing piece

Historically, Indian pharmaceutical companies have focused on generics and services businesses, which carry lower risk and shorter development

BIRAC nurturing the biotech sector; Turning bars into classrooms

Several successful biotech startups trace their roots to BIRAC. Cleantech company GPS Renewables, for example, received funding under BIRAC’s Biotechnology Ignition Grant.

<![CDATA[The Evolving Relationship Between FDA and Biotech]]>

Three-year biotech policy drafted

Policy designed to enhance agricultural output, adopt global farming practices

Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization

The workflow pairs Bio-Techne’s MauriceFlex imaged capillary isoelectric focusing fractionation system with Refeyn's TwoMP mass photometry platform to connect charge heterogeneity...

India’s lifesciences sector sees momentum build in innovation: BCG -HealthKois report

Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March 2026, and biotech startups grew from roughly 1,500 to 2,40...

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Biotech Firm Says It Can Cut Gene Therapy Production Time To One Day

A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks or months to manufacture, MedTherapy says it has signi...

Beyond Boston: Unlikely cities stake biotech claims

As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

2 Biotech Stocks Worth Buying Before Their Potential Buyouts

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

SHENZHEN, China, July 5, 2026 /PRNewswire/ -- MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two...

UK Biotech

UK Biotech Day is an international premier event for life science leaders, innovators, investors and service providers. Our mission is to unite the UK’s vibrant biotech ecosystem,...

Is Bio-Techne Corporation (TECH) A Good Stock To Buy Now?

The next tech war? Why biotech may become a new US-China battleground

The wide-ranging geopolitical rivalry between Beijing and Washington could soon expand into biotechnology, raising the prospect of fresh tensions even as American pharmaceutical fi...

Taiwan's biopharma sector steps into spotlight with rush of IPOs

Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage

Puerto Rico makes its case as a biotech manufacturing hub

Puerto Rico is building on its pharma manufacturing legacy to attract advanced therapy developers seeking scale, regulatory alignment and speed.

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

Danaher Reveals Why Bioprocessing Is Essential for the Most Innovative Biotechnology Companies

Danaher stands among the most innovative biotechnology companies by addressing in a new article the central challenge of modern medicine — building manufacturing infrastructure to...

Bacterial Expression Tech Prompts NorthX and enGenes Collaboration

Interest in E.coli-based expression systems is growing as biopharma firms look for faster and cheaper ways of making proteins at commercial scale, prompting the new partnership bet...

Nirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Tech

TALOS represents an advancement in protein quantitation, enabling rapid, consistent measurements with operational simplicity. These capabilities make it well-suited for modern biop...

Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push

An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.